Cancer associated fibroblasts phenotypic and functional heterogeneity
Frontiers in Bioscience · 2020 · 25 (5) · 961-978
DOI: 10.2741/4843 ↗At a glance
Übersichtsarbeit in Frontiers in Bioscience, 2020. Written by Ankit Kumar Patel and 1 co-authors. Institution: National Institute of Biomedical Genomics, Kalyani, WB, India. Major MEDLINE topics: Cell Communication, Tumor Microenvironment. Cited 23 times so far (Crossref).
Abstract (original language)
Cancer associated fibroblasts (CAFs) are the most abundant stromal cell-type in solid tumor-microenvironment (TME) and have emerged as key player in tumor progression. CAFs establish communication with cancer cells through paracrine mechanisms or via direct cell adhesion as well as influence the cancer cell behaviour indirectly by remodelling the extracellular matrix. Although numerous studies have strongly suggested the tumor promoting role of CAFs, few recent reports have revealed the heterogeneity in CAFs. Here, we have summarized the recent findings on the mechanisms related to the heterogeneous behaviour of CAFs serving as positive or negative regulator of tumor progression. Further, reports related to the targeted therapy against CAF-mediated mechanisms are also summarized briefly.
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- National Institute of Biomedical Genomics, Kalyani, WB, India.
- National Institute of Biomedical Genomics, Kalyani, WB, India, ss5@nibmg.ac.in.
Cite
APA
Patel, A. K., & Singh, S. (2020). Cancer associated fibroblasts phenotypic and functional heterogeneity. Frontiers in Bioscience, 25(5), 961-978. https://doi.org/10.2741/4843
Vancouver
Patel AK, Singh S. Cancer associated fibroblasts phenotypic and functional heterogeneity. Frontiers in Bioscience. 2020;25(5):961-978. doi:10.2741/4843
BibTeX
@article{Patel2020,
author = {Patel, Ankit Kumar and Singh, Sandeep},
title = {Cancer associated fibroblasts phenotypic and functional heterogeneity},
journal = {Frontiers in Bioscience},
year = {2020},
volume = {25},
number = {5},
pages = {961--978},
doi = {10.2741/4843}
}
EUVIMED